Provided by Tiger Trade Technology Pte. Ltd.

Entrada Therapeutics, Inc.

11.15
+0.11001.00%
Volume:76.31K
Turnover:842.20K
Market Cap:426.14M
PE:-4.43
High:11.21
Open:10.99
Low:10.58
Close:11.04
52wk High:13.82
52wk Low:4.93
Shares:38.22M
Float Shares:21.58M
Volume Ratio:0.57
T/O Rate:0.35%
Dividend:- -
Dividend Rate:- -
EPS(TTM):-2.5151
EPS(LYR):1.68
ROE:-27.11%
ROA:-15.71%
PB:1.25
PE(LYR):6.64

Loading ...

Jan 08, 2026

Major Issues Report

Form 8-K - Current report
Nov 21, 2025

Proposed Sale Of Securities

Form 144 - Report of proposed sale of securities
Nov 14, 2025

Proposed Sale Of Securities

Form 144 - Report of proposed sale of securities
Nov 06, 2025

Quarterly Report

Form 10-Q - Quarterly report [Sections 13 or 15(d)]
Nov 06, 2025

Major Issues Report

Form 8-K - Current report
Aug 06, 2025

Quarterly Report

Form 10-Q - Quarterly report [Sections 13 or 15(d)]
Aug 06, 2025

Major Issues Report

Form 8-K - Current report
Jul 09, 2025

Proposed Sale Of Securities

Form 144 - Report of proposed sale of securities
Jul 09, 2025

Proposed Sale Of Securities

Form 144 - Report of proposed sale of securities
Jul 01, 2025

Proposed Sale Of Securities

Form 144 - Report of proposed sale of securities
Jul 01, 2025

Proposed Sale Of Securities

Form 144 - Report of proposed sale of securities
Jun 30, 2025

Proposed Sale Of Securities

Form 144 - Report of proposed sale of securities
Jun 30, 2025

Proposed Sale Of Securities

Form 144 - Report of proposed sale of securities
Jun 27, 2025

Proposed Sale Of Securities

Form 144 - Report of proposed sale of securities
Jun 27, 2025

Proposed Sale Of Securities

Form 144 - Report of proposed sale of securities
Jun 11, 2025

Major Issues Report

Form 8-K - Current report
Jun 03, 2025

Major Issues Report

Form 8-K - Current report
May 08, 2025

Quarterly Report

Form 10-Q - Quarterly report [Sections 13 or 15(d)]
May 08, 2025

Major Issues Report

Form 8-K - Current report
Apr 30, 2025

Major Issues Report

Form 8-K - Current report